IA
STOK icon

Inspire Advisors’s Stoke Therapeutics STOK Stock Holding History

Inspire Advisors’s Portfolio STOK Stock Details STOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276K Buy
+8,423
New +$270K 0.02% 562

Other funds holding STOK

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Inspire Advisors's STOK Position: Q2 2026 in Review

Inspire Advisors opened a new position in Stoke Therapeutics (STOK) in Q2 2026: 8,423 shares worth $276K. The stake represents 0.02% of the portfolio and ranks #562 among its holdings.

198 funds tracked by Wall St. Rank hold STOK as of Q2 2026.

  • Inspire Advisors held 8,423 shares of Stoke Therapeutics worth $276K as of Q2 2026.
  • Stoke Therapeutics was a new Inspire Advisors position in Q2 2026.
  • Stoke Therapeutics made up 0.02% of Inspire Advisors's portfolio in Q2 2026, its #562 holding.
  • 198 funds tracked by Wall St. Rank held Stoke Therapeutics as of Q2 2026.

Based on Inspire Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.